Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowJanuary 22, 2026 — 3:45 PM - 4:00 PM ET
Nasdaq MarketSite, 4 Times Square, New York
NervGen Pharma (Nasdaq: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Adam Rogers, MD, Chief Executive Officer of NervGen Pharma rings the Closing Bell.
